$0.9892
Comments
Loading...
Epitomee Medical Analyst Ratings and Price Targets | OTC:EPTMF | Benzinga
Epitomee Medical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Epitomee Medical Corp from these most-recent analyst ratings.
Analyst Ratings for Epitomee Medical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Epitomee Medical (EPTMF) stock?
There is no price target for Epitomee Medical
What is the most recent analyst rating for Epitomee Medical (EPTMF)?
There is no analyst for Epitomee Medical
When was the last upgrade for Epitomee Medical (EPTMF)?
There is no last upgrade for Epitomee Medical
When was the last downgrade for Epitomee Medical (EPTMF)?
There is no last downgrade for Epitomee Medical.
When is the next analyst rating going to be posted or updated for Epitomee Medical (EPTMF)?
There is no next analyst rating for Epitomee Medical.
Is the Analyst Rating Epitomee Medical (EPTMF) correct?
There is no next analyst rating for Epitomee Medical.
Browse analyst ratings and price targets on all stocks.
